0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Novo Nordisk A/S - Trending symbols

Latest News of Novo Nordisk A/S

DateTitleRead
2025-04-22
22:06
Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity PillRead
2025-04-22
20:07
Novo Nordisk (NVO) Is a Good Short-Term Pick, Wealth Manager SaysRead
2025-04-18
21:20
Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition GrowsRead
2025-04-18
17:46
Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic ManufacturingRead
2025-04-18
17:25
Eli Lilly jumps as results from weight-loss pill study rival competitor’sRead
2025-04-17
22:29
How Eli Lilly's GLP-1 pill could transform the weight-loss spaceRead
2025-04-17
20:41
Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug raceRead
2025-04-16
20:37
Novo Nordisk A/S (NVO): A Bull Case TheoryRead
2025-04-15
22:20
Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA AlertsRead
2025-04-15
20:52
Is Novo Nordisk A/S (NVO) the Best Pharma Stock to Buy for Long Term Growth?Read



Trends

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Long-term Assets Other -43,906,113-4,308,267-48,214,380-3,898,770-52,113,150718,177-51,394,97353,572,9732,178,000
Interest Expense 1,076,154-925,919150,236-112,61037,626252,669290,295-571,619-281,324
Interest Income 428,480-314,397114,083-27,45086,633357,647444,280-821,878-377,598

Comments

How you think about this?

Leave a comment

Stay informed about Novo Nordisk A/S.

Receive notifications about Novo Nordisk A/S in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.